66% of those with lupus will develop some form of skin disease. In this episode of The Expert Series, Victoria Werth, MD will teach you about how lupus can affect the skin as she describes skin lupus ...

It’s hard to say if a mask is causing your lesions or if a mask is causing an irritation to your skin. If you’re having a flare, it’s important to talk with your doctor to determine the cause of your ...

This new research may help investigators prevent skin lesions. New research into the skin cells of patients with lupus offers insights into the underlying mechanisms that appear to prime the skin for ...

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

Jan. 24, 2003 — Thalidomide may be an effective approach to treating cutaneous manifestations of systemic lupus erythematosus (LE), according to the results of a retrospective medical record review ...

Black patients have a three- to five-fold increased incidence of primary chronic cutaneous lupus vs. white patients, but are often completely missing from training materials and most images of ...

Lupus erythematosus is a heterogeneous autoimmune disorder that frequently manifests with distinctive cutaneous involvement. The cutaneous lesions, which range from a malar rash to more indurated, ...

A new study finds that the normal-appearing skin of lupus patients contains the same inflammatory signals that are detected when the skin develops a rash, sometimes at even higher levels. Researchers ...

Keratinocytes in seemingly healthy skin taken from lupus patients were found to be secreting type 1 interferons, which in turn appeared to "educate" dendritic cells that were "prominent in lesional ...

A marijuana-like compound holds out promise as a new treatment for a severe autoimmune skin disease called skin lupus, according to a study published recently by a multicenter team including ...

Thalidomide was developed as a non-barbiturate sedative (non-addictive sleep aid) in Germany during the 1950s. It was removed from the market in 1961 after it was linked to major birth defects in ...